Latest Asx Disclosures News

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.

Bounty Oil & Gas has clarified that no undisclosed information explains the recent surge in its share trading, linking activity to an ongoing Federal Court hearing on the PEP 11 project now adjourned to Sydney.

BPH Energy has responded to ASX inquiries about unusual trading activity, confirming no undisclosed information and highlighting ongoing Federal Court proceedings related to the PEP 11 project.

Control Bionics Limited has confirmed its compliance with ASX continuous disclosure rules following an inquiry about the timing and content of its financial results announcements.

Ramsay Health Care has clarified that its underlying earnings for FY25 aligned closely with market consensus, despite a significant non-cash impairment impacting statutory profits. The company confirms compliance with ASX disclosure rules amid share price volatility.

Global Lithium Resources Limited has clarified that recent spikes in its share price and trading volume are linked to previously announced project developments, not undisclosed information.

Rewardle Holdings clarifies its complex relationship with CloudHolter and updates on Pepper Leaf loan litigation, addressing ASX concerns over financial reporting delays.

RPMGlobal Holdings clarifies the reasons behind withdrawing its FY2025 earnings guidance following the divestment of its Advisory business, providing detailed updates on software segment performance and compliance with ASX disclosure rules.

Codan Limited has clarified that its FY25 financial results aligned closely with market forecasts despite a notable share price jump following its earnings release. The company detailed its compliance with ASX disclosure rules and attributed the price movement to broader macroeconomic factors.

Invion Limited has affirmed its compliance with ASX disclosure rules following the US FDA’s granting of Orphan Drug Designation for its anal cancer treatment candidate INV043. The company detailed the timing and verification process behind its announcement.

Pengana International Equities has acknowledged breaching ASX disclosure rules by sharing details of a new private credit strategy with media before official announcement, prompting a policy overhaul.

Ian Ferrier, founder and long-standing board member of Energy One Limited, has sold a portion of his shares but reassures investors of his ongoing commitment to the company.